Genedrive (GDR)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.45p
   
  • Change Today:
      0.050p
  • 52 Week High: 9.50p
  • 52 Week Low: 1.45p
  • Currency: UK Pounds
  • Shares Issued: 543.14m
  • Volume: 15,276,844
  • Market Cap: £13.31m
  • RiskGrade: 747
  • Beta: 1.17

Latest ShareCast News

Director dealings: Genedrive chairman snaps up shares

By Iain Gilbert

Date: Thursday 15 Aug 2024

(Sharecast News) - Genedrive revealed on Thursday that chairman Ian Gilham had acquired 1.0m shares in the AIM-listed pharmacogenetic testing company.

Genedrive makes first commercial sales of CYP2C19-ID testing kit

By Iain Gilbert

Date: Monday 12 Aug 2024

(Sharecast News) - Pharmacogenetic testing firm Genedrive said on Monday that it has made the first UK commercial sales of its CYP2C19-ID testing kit.

Genedrive test ordered by five Manchester area hospitals

By Josh White

Date: Friday 24 May 2024

(Sharecast News) - Point-of-care pharmacogenetic testing company Genedrive announced on Friday that it has received initial orders for its Genedrive MT-RNR1 products from five additional UK hospitals in the Greater Manchester area.

Genedrive shares jump on NICE test recommendation 03-Apr-2024 ShareCast
Genedrive receives R&D tax credit, plans fundraise 15-Mar-2024 ShareCast
Genedrive set to apply for NICE EVA funding 19-Feb-2024 ShareCast
Genedrive confirms £0.6m equity prepayment drawd... 02-Jan-2024 ShareCast
Genedrive gets first product orders from several... 20-Dec-2023 ShareCast
Genedrive diagnostic test system gets UKCA regis... 06-Sep-2023 ShareCast
Genedrive draws down £0.3m under equity prepayme... 05-Jul-2023 ShareCast
Genedrive secures multi-partner grant award 16-Jun-2023 ShareCast
Genedrive jumps on draft NICE testing guidance 19-May-2023 ShareCast
Genedrive engages with US FDA over infant test 05-Oct-2022 ShareCast
Genedrive test to go through new, faster NICE pr... 26-Sep-2022 ShareCast
Another Genedrive test to be assessed by NICE 22-Aug-2022 ShareCast
Genedrive test to be evaluated by NICE 16-Jun-2022 ShareCast
Genedrive rallies on positive news about hearing... 29-Mar-2022 ShareCast
Genedrive finance chief announces April departure 02-Mar-2022 ShareCast
Genedrive makes progress with rapid Covid-19 tes... 23-Feb-2022 ShareCast
Genedrive submits new Covid-19 test for EU certi... 29-Nov-2021 ShareCast
 

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genedrive Market Data

Currency UK Pounds
Share Price 2.45p
Change Today 0.050p
% Change 2.08 %
52 Week High 9.50p
52 Week Low 1.45p
Volume 15,276,844
Shares Issued 543.14m
Market Cap £13.31m
Beta 1.17
RiskGrade 747

Genedrive Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
50.94% below the market average50.94% below the market average50.94% below the market average50.94% below the market average50.94% below the market average
42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average42.86% below the sector average
Price Trend
37.11% below the market average37.11% below the market average37.11% below the market average37.11% below the market average37.11% below the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average
Income Not Available
Growth
42.21% below the market average42.21% below the market average42.21% below the market average42.21% below the market average42.21% below the market average
55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average55.56% below the sector average

Genedrive Dividends

No dividends found

Trades for 21-Nov-2024

Time Volume / Share Price
16:06 7,000 @ 2.41p
15:55 200,000 @ 2.48p
15:40 102,045 @ 2.45p
15:36 200,000 @ 2.40p
15:35 24,000 @ 2.45p

Genedrive Key Personnel

CFO Russell Shaw
CEO Gino Miele

Top of Page